Word

DEL-DESIRAN

Status

Pending

Status Code

630

Status Date

Friday, April 5, 2024

Serial Number

98486061

Mark Type

4000

Filing Date

Friday, April 5, 2024

Trademark Owner History

Avidity Biosciences, Inc.

Classifications

5 Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

42 Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Trademark Events

Apr 5, 2024

New Application Entered